Blogs
INSIGHTS & ARTICLES
DnXT Blog
Expert insights on regulatory operations, eCTD publishing, and digital transformation in life sciences.
Regulatory Affairs in 2026: Beyond Document Management
How AI is transforming regulatory affairs from document management to intelligent compliance. Enterprise authoring and analysis at scale.
Submission Planning Shouldn’t Live in Spreadsheets
DNXT New Planner streamlines pharmaceutical submission management, eliminating fragmented planning processes that cause missed deadlines and delays, potentially saving millions in lost revenue.
2025 State of Regulatory Operations: Industry Benchmarks and Trends
Download the 2025 industry benchmark report for regulatory operations. Resource constraints, costs, and how leading teams are transforming.
The Real Cost of Enterprise RIM: What Vendors Won’t Show You
Enterprise RIM pricing goes far beyond the license fee. Here's the full cost picture for growing biotech — and what to look for in alternatives.
eCTD 4.0: What Senior Regulatory Leaders Need to Know Now
eCTD 4.0 moves to HL7 RPS — a fundamental shift. Here's what regulatory teams at emerging biotech need to prepare for and what to ask your vendor.
Why We’re Not Veeva (And Why That’s the Point)
Enterprise RIM platforms are overbuilt and overpriced for growing biotech. DnXT is cloud-native eCTD publishing built for the companies the big guys ignore.
Bulletproof AI Security: How DNXT’s Self-Hosted LLM Protects Your Regulatory Data from External Breaches
In pharmaceutical document management, data security isn’t just important—it’s mission-critical. When sensitive regulatory documents contain proprietary formulations, clinical trial data, and submission strategies worth millions, the last thing you want...
How Remote Regulatory Teams Drive 40% Faster Drug Approvals While Cutting Operational Costs
The Remote Revolution in Pharmaceutical Regulatory Affairs The pharmaceutical industry’s shift to distributed regulatory teams isn’t just a trend—it’s a strategic imperative. Companies managing remote regulatory operations are experiencing faster...
Why Smart Pharma Companies Are Winning the Regulatory Technology Investment Battle
The CFO Question Every Regulatory Leader Faces “How do you justify spending millions on regulatory technology when budgets are already stretched thin?” If you’ve been in pharma regulatory for more...
Stop Regulatory Document Chaos: Master Version Control for Pharma Compliance
The Hidden Cost of Document Confusion Picture this: Your regulatory team is preparing for a critical FDA submission when someone discovers they’ve been working on an outdated document version for...
How to Master Global Regulatory Submissions Across Multiple Markets Without Breaking Your Budget
The Global Regulatory Challenge That’s Costing You Time and Money Your breakthrough pharmaceutical product is ready for the world, but navigating simultaneous submissions to the FDA, EMA, Health Canada, and...
Master Your eCTD 4.0 Migration: The Complete Strategic Guide for Regulatory Success
The Clock Is Ticking: Why eCTD 4.0 Migration Can’t Wait Pharmaceutical companies worldwide face a critical transition that could make or break their regulatory submission success. The migration from eCTD...
